A randomized trial of human chorionic gonadotropin support following in vitro fertilization and embryo transfer. 1988

J Buvat, and G Marcolin, and J C Herbaut, and J L Dehaene, and P Verbecq, and J C Fourlinnie
Association EPARP, Lille, France.

This article reports on the effects of human chorionic gonadotropin (hCG) on progesterone (P) and estradiol (E2), luteal phase length, and conception in 116 cycles treated by in vitro fertilization and embryo transfer (IVF-ET). In 60 cycles, the luteal phase was supported by hCG, 1500 IU three times at 2-day intervals from the day of ET. The remaining 56 cycles served as controls. hCG significantly increased the P level (93 +/- 53 versus 62 +/- 46 ng/ml), the P/E2 ratio, and the luteal phase length (17.4 +/- 1.3 versus 12.2 +/- 1.7 days). However, the total pregnancy rate did not significantly differ between the two groups, though the pregnancy rate after transfer of two or three embryos was slightly higher in the hCG group (26.9 versus 22% in the control group), as was the rate of implanted embryo per transferred embryo after transfer of two or three embryos (25 versus 15.3%). It was concluded that, while hCG increased the magnitude and duration of the luteal P secretion, it did not clearly improve the pregnancy rate.

UI MeSH Term Description Entries
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004624 Embryo Transfer The transfer of mammalian embryos from an in vivo or in vitro environment to a suitable host to improve pregnancy or gestational outcome in human or animal. In human fertility treatment programs, preimplantation embryos ranging from the 4-cell stage to the blastocyst stage are transferred to the uterine cavity between 3-5 days after FERTILIZATION IN VITRO. Blastocyst Transfer,Tubal Embryo Transfer,Tubal Embryo Stage Transfer,Embryo Transfers,Transfer, Embryo,Transfers, Embryo
D005260 Female Females
D005307 Fertilization in Vitro An assisted reproductive technique that includes the direct handling and manipulation of oocytes and sperm to achieve fertilization in vitro. Test-Tube Fertilization,Fertilizations in Vitro,In Vitro Fertilization,Test-Tube Babies,Babies, Test-Tube,Baby, Test-Tube,Fertilization, Test-Tube,Fertilizations, Test-Tube,In Vitro Fertilizations,Test Tube Babies,Test Tube Fertilization,Test-Tube Baby,Test-Tube Fertilizations
D006063 Chorionic Gonadotropin A gonadotropic glycoprotein hormone produced primarily by the PLACENTA. Similar to the pituitary LUTEINIZING HORMONE in structure and function, chorionic gonadotropin is involved in maintaining the CORPUS LUTEUM during pregnancy. CG consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is virtually identical to the alpha subunits of the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity (CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN). Chorionic Gonadotropin, Human,HCG (Human Chorionic Gonadotropin),Biogonadil,Choriogonadotropin,Choriogonin,Chorulon,Gonabion,Human Chorionic Gonadotropin,Pregnyl,Gonadotropin, Chorionic,Gonadotropin, Human Chorionic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J Buvat, and G Marcolin, and J C Herbaut, and J L Dehaene, and P Verbecq, and J C Fourlinnie
April 1990, Human reproduction (Oxford, England),
J Buvat, and G Marcolin, and J C Herbaut, and J L Dehaene, and P Verbecq, and J C Fourlinnie
January 2015, Gynecologic and obstetric investigation,
J Buvat, and G Marcolin, and J C Herbaut, and J L Dehaene, and P Verbecq, and J C Fourlinnie
July 2019, Fertility and sterility,
J Buvat, and G Marcolin, and J C Herbaut, and J L Dehaene, and P Verbecq, and J C Fourlinnie
January 2014, Iranian journal of reproductive medicine,
J Buvat, and G Marcolin, and J C Herbaut, and J L Dehaene, and P Verbecq, and J C Fourlinnie
April 1988, Journal of in vitro fertilization and embryo transfer : IVF,
J Buvat, and G Marcolin, and J C Herbaut, and J L Dehaene, and P Verbecq, and J C Fourlinnie
July 1988, Fertility and sterility,
J Buvat, and G Marcolin, and J C Herbaut, and J L Dehaene, and P Verbecq, and J C Fourlinnie
July 1993, The Online journal of current clinical trials,
J Buvat, and G Marcolin, and J C Herbaut, and J L Dehaene, and P Verbecq, and J C Fourlinnie
December 1984, Fertility and sterility,
J Buvat, and G Marcolin, and J C Herbaut, and J L Dehaene, and P Verbecq, and J C Fourlinnie
July 1978, Fertility and sterility,
J Buvat, and G Marcolin, and J C Herbaut, and J L Dehaene, and P Verbecq, and J C Fourlinnie
March 1986, Fertility and sterility,
Copied contents to your clipboard!